Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenkang Shuan
- Development stage
- Unknown
- Lead developer
- Xi'an Century Shenkang Pharmaceutical
- Modality
- Small Molecules
- Administration
- Rectal
01
Overview
Shenkang Shuan is a Traditional Chinese Medicine (TCM) herbal suppository developed and manufactured by Xi'an Century Shenkang Pharmaceutical Industry. It is a multi-herb formulation composed of four primary botanical ingredients: rhubarb (*Rheum palmatum*), salvia (*Salvia miltiorrhiza*), safflower (*Carthamus tinctorius*), and astragalus (*Astragalus membranaceus*). The medication is specifically indicated for the treatment of chronic renal insufficiency resulting from chronic nephritis, chronic pyelonephritis, and hypertensive nephropathy. Administered rectally, the formulation is designed to promote blood circulation, resolve blood stasis, and facilitate the excretion of nitrogenous waste (descending turbidity) through the rectal mucosa. As a complex TCM product, its therapeutic effects are attributed to the synergistic action of various phytochemicals, such as anthraquinones and tanshinones, rather than a single molecular target.
- Brand names
- Shenkang Shuan肾康栓
- Other names
- Shenkang SuppositoryShenkangshuan
Beyond the preview
Go deeper on Shenkang Shuan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenkang Shuan.